Impact of the Covid-19 Pandemic on Quality of Life of Patients with CML

Introduction Introduction of imatinib and other tyrosine kinase inhibitors (TKIs) dramatically improved the quality of life (QoL) of patients with chronic myeloid leukemia (CML). However, the impact of Covid-19 on the QoL of patients with CML has not been measured so far. We aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wysoglad, Hubert, Szczepanek, Elzbieta, Chukwu, Ositadima, Lebowa, Weronika, Nowak, Wiktor, Sacha, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
632.Chronic Myeloid Leukemia: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701481/
http://dx.doi.org/10.1182/blood-2021-153742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701481/
http://dx.doi.org/10.1182/blood-2021-153742

Ejemplares similares